Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Cotellic
Cobimetinib hemifumarate 22.2mg equivalent to cobimetinib 20mg
Film coated tablet
Roche Products (NZ) Limited
F Hoffmann-La Roche Limited, Basel, Switzerland

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Dysport
Clostridium botulinum type A toxin haemagglutinin complex 300U
Powder for injection
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Ipsen Biopharm Limited, Wrexham, United Kingdom

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Dysport
Clostridium botulinum type A toxin haemagglutinin complex 500U
Powder for injection
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Ipsen Biopharm Limited, Wrexham, United Kingdom

Product:
Active Ingredient:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Glycophos
Sodium glycerophosphate pentahydrate 306.1mg/mL
equivalent to sodium glycerophosphate anhydrous 216mg/mL
Concentrate for infusion
Fresenius Kabi New Zealand Limited
Fresenius Kabi Norge AS, Halden, Norway

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Zipzoc
Zinc oxide 20%w/w
Medicated dressing
Smith & Nephew Limited
Perstorp Pharma, Perstorp, Sweden
Purna Pharmaceuticals NV, Puurs, Belgium

Dated this 11th day of February 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).